Albano L et al. |
OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation. |
2013 |
Transplantation |
pmid:23982340
|
Troppmann C et al. |
Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. |
2003 |
Transplantation |
pmid:12883205
|
Marcos A et al. |
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. |
2004 |
Transplantation |
pmid:15480160
|
Neuhaus P et al. |
Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. |
1995 |
Transplantation |
pmid:7530868
|
Heeckt PF et al. |
Functional impairment of enteric smooth muscle and nerves caused by chronic intestinal allograft rejection regresses after FK506 rescue. |
1995 |
Transplantation |
pmid:7530870
|
Moss MC et al. |
Lithium use for bipolar disorder post renal transplant: is mood stabilization without toxicity possible? |
2014 |
Transplantation |
pmid:24492429
|
Fridell JA et al. |
Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. |
2006 |
Transplantation |
pmid:16906038
|
Boldt A et al. |
The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo. |
2006 |
Transplantation |
pmid:16906043
|
Reutzel-Selke A et al. |
Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors. |
2003 |
Transplantation |
pmid:12811235
|
Gaber AO et al. |
Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal. |
2013 |
Transplantation |
pmid:23423269
|
Molano RD et al. |
Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. |
2003 |
Transplantation |
pmid:12811239
|
Hoffman AL et al. |
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. |
1990 |
Transplantation |
pmid:1690469
|
Jain A et al. |
Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection. |
2014 |
Transplantation |
pmid:25285953
|
Valdivia LA et al. |
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. |
1993 |
Transplantation |
pmid:7681230
|
Shapiro R et al. |
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. |
1995 |
Transplantation |
pmid:7533343
|
Sakr M et al. |
The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. |
1992 |
Transplantation |
pmid:1374948
|
Gonwa TA et al. |
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. |
2001 |
Transplantation |
pmid:11773892
|
Singh N et al. |
Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of microbial etiologies. |
1996 |
Transplantation |
pmid:8610349
|
Fisher RA et al. |
A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. |
1998 |
Transplantation |
pmid:9884248
|
Johansson A and Möller E |
Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical. |
1990 |
Transplantation |
pmid:1701570
|
Egidi MF and Gaber AO |
Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. |
2003 |
Transplantation |
pmid:12605133
|
Ciancio G et al. |
Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506. |
1997 |
Transplantation |
pmid:9075856
|
Cooper MH et al. |
Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors. |
1994 |
Transplantation |
pmid:7509089
|
Camirand G et al. |
Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice. |
2001 |
Transplantation |
pmid:11468532
|
Squifflet JP et al. |
Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. |
2001 |
Transplantation |
pmid:11468536
|
Yu S et al. |
Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. |
2006 |
Transplantation |
pmid:16421475
|
Jurcevic S et al. |
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. |
1998 |
Transplantation |
pmid:9603168
|
Borrows R et al. |
Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16421488
|
Macphee IA et al. |
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement. |
2002 |
Transplantation |
pmid:12490779
|
Shapiro AM et al. |
Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts. |
2002 |
Transplantation |
pmid:12490784
|
Andries S et al. |
Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. |
2001 |
Transplantation |
pmid:11477351
|
Ho ET et al. |
Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review. |
2013 |
Transplantation |
pmid:23542469
|
Taler SJ et al. |
Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. |
1996 |
Transplantation |
pmid:8970613
|
Porrini E et al. |
Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study. |
2008 |
Transplantation |
pmid:18431233
|
Veroux M et al. |
Impact of conversion to a once daily tacrolimus-based regimen in kidney transplant recipients with gastrointestinal complications. |
2012 |
Transplantation |
pmid:22298033
|
Naesens M et al. |
Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients. |
2008 |
Transplantation |
pmid:18431234
|
Rodriguez Rilo HL et al. |
Rapid hair regrowth in refractory alopecia universalis associated with autoimmune disease following liver transplantation and tacrolimus (FK506) therapy. |
1995 |
Transplantation |
pmid:7539169
|
MacDonald AS |
Management strategies for nephrotoxicity. |
2000 |
Transplantation |
pmid:10910262
|
Reyes J et al. |
Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. |
2000 |
Transplantation |
pmid:10910279
|
Higgins RM et al. |
Conversion from tacrolimus to cyclosporine in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. |
2000 |
Transplantation |
pmid:10836393
|
Garton T |
Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1. |
2002 |
Transplantation |
pmid:12352898
|
Cantarovich D et al. |
Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events. |
2005 |
Transplantation |
pmid:15714172
|
Yamauchi A et al. |
Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. |
2002 |
Transplantation |
pmid:12352921
|
Nguyen L et al. |
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients. |
2012 |
Transplantation |
pmid:22960763
|
Peng Y et al. |
Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. |
2013 |
Transplantation |
pmid:23263506
|
Kuypers DR et al. |
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. |
2013 |
Transplantation |
pmid:23263559
|
Shapiro R et al. |
Tacrolimus in pediatric renal transplantation. |
1996 |
Transplantation |
pmid:8990356
|
White M et al. |
Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. |
2006 |
Transplantation |
pmid:17006323
|
Starzl TE et al. |
Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin. |
1991 |
Transplantation |
pmid:1718068
|
Foster RD et al. |
Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. |
2003 |
Transplantation |
pmid:14508367
|